Notificateur communications tool: Preventive measure for influenza A virus

In preparation for the second wave of the influenza A (H1N1) virus, Hi-VOS proposes a fast and effective communications tool to help public institutions and businesses better communicate with various groups among the Canadian population: employees, parents, students and clients. The Notificateur, a notification system developed in Québec, enables authorities to contact thousands of people per minute by cellular phone, telephone, text messaging (SMS), pager, fax or e-mail.

"Canadians want to be kept informed of recent developments with regards to the next wave of the influenza A virus in order to better prepare themselves in office, health and teaching environments", says Pierre Lebrun, President of Hi-Vos. "This technological tool fits perfectly with the continuity plan and measures proposed by the Government of Québec (http://www.pandemiequebec.gouv.qc.ca), which highlights the importance for businesses to effectively communicate with their employees" concludes Lebrun.

The Notificateur tool

Designed in Québec, the Notificateur runs on a 100% Web-based technology, in a secure environment. Its fast and easy installation process does not require any telephone or computer system changes. The software is completely bilingual and allows users to almost instantly contact all individuals appearing on institutional and corporate listings.

Besides helping public institutions and businesses manage their communications in the event of a new influenza A pandemic, the Notificateur enables them to communicate urgent messages in real time, such as shutdowns during storms, the interruption of public services and schedule changes. It also facilitates the management of vaccination notices when these are automated during the first visit.

Source: DUVAL, DEVELOPPEMENT DES AFFAIRES INC.

Source: NOTIFICATEUR

Source: HI-VOS

Source: HI-VOS.COM

Source:

FLU VIRUS UPDATE

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO announces recommended viral composition for 2025 influenza vaccines